Clinical impacts of copy number variations in B-cell differentiation and cell cycle control genes in pediatric B-cell acute lymphoblastic leukemia: a single centre experience

被引:8
|
作者
Crepinsek, Klementina [1 ,2 ]
Marinsek, Gasper [1 ]
Kavcic, Marko [2 ,3 ]
Prelog, Tomaz [3 ]
Kitanovski, Lidija [3 ]
Jazbec, Janez [2 ,3 ]
Debeljak, Marusa [1 ,2 ]
机构
[1] Univ Med Ctr Ljubljana, Univ Childrens Hosp, Clin Inst Special Lab Diagnost, Vrazov Trg 1, Ljubljana 1000, Slovenia
[2] Univ Ljubljana, Fac Med, Ljubljana, Slovenia
[3] Univ Med Ctr Ljubljana, Univ Childrens Hosp, Dept Oncol & Haematol, Ljubljana, Slovenia
关键词
B-acute lymphoblastic leukemia; IKZF1; deletions; IKZF1(plus); MLPA; pediatric; copy number variations (CNVs); IKZF1; DELETION; IKAROS GENE; PROGNOSTIC MARKER; POOR-PROGNOSIS; PRECURSOR; CHILDHOOD; CHILDREN; PAX5; STRATIFICATION; CLASSIFICATION;
D O I
10.2478/raon-2021-0050
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background IKZF1 gene deletions have been identified as a poor prognostic factor in pediatric B-cell acute lymphoblastic leukemia (B-ALL), especially in the presence of co-occurring deletions (IKZF1(plus) profile). This study aimed to determine the frequency of IKZF1 deletions and deletions in other B-cell differentiation and cell cycle control genes, and their prognostic impact in Slovenian pediatric B-ALL patients. Patients and methods We studied a cohort of 99 patients diagnosed with B-ALL from January 2012 to December 2020 and treated according to the ALL IC-BFM 2009 protocol. Eighty-eight bone marrow or peripheral blood samples were analysed for copy number variations (CNVs) using the SALSA MLPA P335 ALL-IKZF1 probemix. Results At least one CNV was detected in more than 65% of analysed samples. The most frequently altered genes were PAX5 and CDKN2A/B (30.7%, 26.1%, and 25.0%, respectively). Deletions in IKZF1 were present in 18.2% of analysed samples and were associated with an inferior 5-year event-free survival (EFS; 54.8% vs. 85.9%, p = 0.016). The IKZF1(plus) profile was identified in 12.5% of the analysed samples, and these patients had an inferior 5-year EFS than those with deletions in IKZF1 only and those without deletions (50.8% vs. 75.0% vs. 85.9%, respectively, p = 0.049). Overall survival (OS) was also worse in patients with the IKZF1(plus) profile than those with deletions in IKZF1 only and those without deletions (5-year OS 76.2% vs. 100% vs. 93.0%, respectively). However, the difference between the groups was not statistically significant. Conclusions Our results are in concordance with the results obtained in larger cooperative clinical trials. Copy number variations analysis using the SALSA MLPA kit is a reliable tool for initial diagnostic approach in children with B-ALL, even in smaller institutions in low- and middle-income countries.
引用
收藏
页码:92 / 101
页数:10
相关论文
共 50 条
  • [31] Clinical use of blinatumomab for B-cell acute lymphoblastic leukemia in adults
    Lee, Kum Ja
    Chow, Vivian
    Weissman, Ashley
    Tulpule, Sunil
    Aldoss, Ibrahim
    Akhtari, Mojtaba
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2016, 12 : 1301 - 1310
  • [32] Tisagenlecleucel for the treatment of B-cell acute lymphoblastic leukemia
    Leahy, Allison Barz
    Elgarten, Caitlin W.
    Grupp, Stephan A.
    Maude, Shannon L.
    Teachey, David T.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2018, 18 (10) : 959 - 971
  • [33] B-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA - CLINICAL AND BIOLOGICAL ASPECTS
    MAZOYER, G
    FFRENCH, M
    MAGAUD, JP
    MANEL, AM
    CHARRIN, C
    GENTILHOMME, O
    BRYON, PA
    CLINICAL AND LABORATORY HAEMATOLOGY, 1988, 10 (02): : 149 - 157
  • [34] B-CELL AND T-CELL ASSAYS IN ACUTE LYMPHOBLASTIC LEUKEMIA
    DEVEBER, LL
    BELL, DA
    PEDIATRIC RESEARCH, 1978, 12 (04) : 479 - 479
  • [35] COMBINED T-CELL AND B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
    HAEGERT, DG
    CAWLEY, JC
    KARPAS, A
    GOLDSTONE, AH
    BMJ-BRITISH MEDICAL JOURNAL, 1974, 4 (5936): : 79 - 82
  • [36] PROGNOSTIC IMPACT OF COPY NUMBER ALTERATIONS IN A SERIES OF PEDIATRIC PATIENTS WITH DE NOVO B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA IN A SINGLE CENTER
    Trabazo Del Castillo, M.
    Rives, S.
    Vega-Garcia, N.
    Malatesta, R.
    Estella, C.
    Catala, A.
    Torrebadell, M.
    Berrueco, R.
    Ruiz-LLobet, A.
    Calvente, L.
    Alonso-Saladrigues, A.
    Mesegue, M.
    Solsona, M.
    Camos, M.
    HAEMATOLOGICA, 2016, 101 : 354 - 354
  • [37] Genome-wide analysis of Philadelphia chromosome-positive (Ph plus ) acute lymphoblastic leukemia (ALL) patients identified recurrent copy number variations in genes regulating the cell cycle and the B-cell differentiation
    Iacobucci, I.
    Ottaviani, E.
    Astolfi, A.
    Testoni, N.
    Storlazzi, T.
    Papayannidis, C.
    Giannoulia, P.
    Foa, R.
    Baccarani, M.
    Martinelli, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [38] B-cell acute lymphoblastic leukemia as a secondary malignancy following diffuse large B-cell lymphoma
    Gaut, Dania
    Bejjani, Anthony
    Sasine, Joshua
    Schiller, Gary
    HEMATOLOGY REPORTS, 2019, 11 (02) : 43 - 45
  • [39] Recovery of the Normal B-Cell Compartment in Children Treated for B-Cell Precursor Acute Lymphoblastic Leukemia
    Theunissen, Prisca
    Mejstrikova, Ester
    Szczepanski, Tomasz
    Sedek, Lukasz
    van der Sluijs, Alita
    Orfao, Alberto
    van Dongen, Jacques J. M.
    van der Velden, Vincent H. J.
    BLOOD, 2014, 124 (21)
  • [40] Molecular characterization and biomarker identification in pediatric B-cell acute lymphoblastic leukemia
    Du, Yu
    Zhang, Xiankai
    Sun, Ming
    Yang, Li
    Long, Fei
    Qi, Shanshan
    Luo, Linlin
    Wang, Chenxuan
    Lv, Xiaoyan
    Wu, Xiaoying
    Zhu, Liuqing
    Ou, Qiuxiang
    Xiong, Hao
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)